Clinical trial
Erythropoietin in Acute Myocardial Infarction
NCT00149058 · Hammersmith Hospitals NHS Trust, Other · Unknown status
Key facts
| NCT number | NCT00149058 |
|---|---|
| Title | Erythropoietin in Acute Myocardial Infarction |
| Official title | A Phase II Randomised Trial to Investigate the Safety and Efficacy of Recombinant Human Erythropoietin on Infarct Size in Patients Undergoing Primary Percutaneous Coronary Angioplasty for ST-Segment Elevation Myocardial Infarction |
| Lead sponsor | Hammersmith Hospitals NHS Trust, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Acute Myocardial Infarction |
| Intervention type | Drug |
| Interventions | Erythropoietin |
| Enrollment | 124 |
| Start date | Oct 1, 2005 |
| Completion | Jan 1, 2008 |
| First posted | Sep 8, 2005 |
| Last update posted | Sep 8, 2005 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: